Weili Zhao, PhD, MD
Ruijin Hospital
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Frank G Basile, M.D.
Schrodinger Inc.
Shared therapeutic areas:
Zhitao Ying, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Darrel P Cohen, MD, PhD
Viracta Therapeutics
Shared therapeutic areas:
Chen-Lung Lin, MD
Pell Bio-Med Technology Co., Ltd.
Shared therapeutic areas:
Thomas GROSS, MD
Children's Oncology Group, USA
Shared therapeutic areas:
Rakhee Vaidya, MBBS
Wake Forest University Health Sciences
Shared therapeutic areas:
Xiaoyu Xiang, PhD
Marino Biotechnology Co., Ltd.
Shared therapeutic areas:
Pier Luigi Zinzani, Prof.
Istituto di Ematologia L. e A. Seragnoli - Bologna - Italy
Shared therapeutic areas:
Lugui Qiu, MD
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL
Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL
All 2 trials loaded